首页 > 市场调查报告书 > 製药

3D列印

市场调查报告书

商品编码

1352945

全球 3D 列印药品市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

Global 3D Printed Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年09月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2030 年，全球 3D 列印药品市场的市场规模将从 2022 年的 77.27 万美元达到近 328.36 万美元，2023-2030 年研究期间复合年增长率为 17.44%。

3D列印药物是透过3D列印技术为个人量身订製的药物，以提高安全性和有效性。 3D 列印药物具有单一的多孔结构，容易在口腔中分散，因此这些高剂量药物无需完整吞嚥。

市场动态：

可在口腔中轻鬆分散的速溶药物的需求增加是推动全球3D列印药物市场成长的主要因素之一。此外，吞嚥困难盛行率的增加、医疗保健行业中 3D 列印技术的使用增加、个人化药物的采用增加以及组合药物的生产促进了市场的成长。此外，人们对药物优势的认识不断提高，例如老年人、婴儿和患有癫痫等癫痫等癫痫病的患者易于服用药物，将确保预测期内的高需求。此外，发展中国家医疗基础设施的改善和技术进步被认为是影响未来几年3D列印药品市场发展的因素。然而，缺乏与 3D 列印药物相关的政府法规以及 3D 列印药物的有害影响可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球 3D 列印药物市场的各个细分市场进行了包容性评估。 3D 列印药品产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 3D 列印药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 3D列印药物市场的主要参与者包括Aprecia、Formac Pharmaceuticals、Extend Biosciences、Affinity Therapeutics、Osmotica Pharmaceuticals、GSK Group of Companies、FabRx Ltd.、Hewlett Packard Caribe、Merck & Co. Inc.、Cycle Pharmaceuticals、阿斯特捷利康。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望销售分析
简介销售分析
北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：3D 列印药品公司的竞争格局

3D列印药品市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

十大公司股票分析
市场集中度
Aprecia

公司简介
公司收入
产品
最近的发展

Formac Pharmaceuticals

公司简介
公司收入
产品
最近的发展

Extend Biosciences

公司简介
公司收入
产品
最近的发展

Affinity Therapeutics

公司简介
公司收入
产品
最近的发展

Osmotica Pharmaceuticals

公司简介
公司收入
产品
最近的发展

GSK Group of Companies

公司简介
公司收入
产品
最近的发展

FabRx Ltd.

公司简介
公司收入
产品
最近的发展

Hewlett Packard Caribe

公司简介
公司收入
产品
最近的发展

Merck & Co. Inc.

公司简介
公司收入
产品
最近的发展

Cycle Pharmaceuticals

公司简介
公司收入
产品
最近的发展

AstraZeneca.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR11218808

The global demand for 3D Printed Drugs Market is presumed to reach the market size of nearly USD 328.36 MN by 2030 from USD 77.27 MN in 2022 with a CAGR of 17.44% under the study period 2023 - 2030.

3D printed drugs are medications designed by 3D printing techniques to customize for individuals for more safety and effectiveness. 3D printed drugs have unitary porous structures that readily disperse in the mouth, as a result of which these high-dose medicines need not be swallowed intact.

MARKET DYNAMICS:

The increase in demand for instantaneous soluble drugs that can disperse easily in the mouth is one of the main factors that drive the growth of the global 3D printed drugs market. Moreover, an increase in the prevalence of dysphagia, a rise in usage of 3D printing techniques in the medical & healthcare industries, an increase in the adoption of personalized drugs, and the production of combination medicine boost the market growth. Furthermore, a rise in awareness about the advantages of the drugs, such as ease of intake of the drugs for the elderly, infants, and patients suffering from seizures-causing diseases such as epilepsy will ensure high demand under the projection period. Additionally, improvement in healthcare infrastructure and technological advancements in developing countries are the factors that are believed to influence the development of the 3D printed drugs market in upcoming years. However, the absence of government regulations related to 3D printed drugs and the harmful effects of 3D printed drugs may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of 3d printed drugs. The growth and trends of 3d printed drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the 3d printed drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Inkjet Printing
Fused Deposition Modeling
Stereolithography
Zipdose Technology

By Application

Orthopedic
Neurology
Dental
Others

By End-Use

Hospitals & Clinics
Research Laboratories
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the 3D Printed Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the 3d printed drugs market include Aprecia, Formac Pharmaceuticals, Extend Biosciences, Affinity Therapeutics, Osmotica Pharmaceuticals, GSK Group of Companies, FabRx Ltd., Hewlett Packard Caribe, Merck & Co. Inc., Cycle Pharmaceuticals, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . 3D PRINTED DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL 3D PRINTED DRUGS MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Inkjet Printing Historic and Forecast Sales by Regions
6.5 Fused Deposition Modeling Historic and Forecast Sales by Regions
6.6 Stereolithography Historic and Forecast Sales by Regions
6.7 ZipDose Technology Historic and Forecast Sales by Regions

7 . GLOBAL 3D PRINTED DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Orthopedic Historic and Forecast Sales by Regions
7.5 Neurology Historic and Forecast Sales by Regions
7.6 Dental Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL 3D PRINTED DRUGS MARKET SALES ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
8.5 Research Laboratories Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL 3D PRINTED DRUGS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE 3D PRINTED DRUGS COMPANIES

10.1. 3D Printed Drugs Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF 3D PRINTED DRUGS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Aprecia
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Formac Pharmaceuticals
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Extend Biosciences
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Affinity Therapeutics
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Osmotica Pharmaceuticals
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. GSK Group of Companies
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. FabRx Ltd.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Hewlett Packard Caribe
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Merck & Co. Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Cycle Pharmaceuticals
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. AstraZeneca.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments